Larimar Therapeutics, Inc.
USD3.13
-0.07 (-2.19%)
CEO
Carole S. Ben-Maimon
IPO Date
2014-06-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.12
Prev. Close
$3.20
Day Low
$3.10
Day High
$3.21
52W Low
$2.71
52W High
$6.42
Market Cap
$0.27B
Volume
0.38M
| -2.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -45.2% | -38.5% | 0.07 | 9.49 | -5.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -31.9% | -28.0% | 0.05 | 11.28 | -3.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -78.6% | -64.4% | 0.09 | 8.16 | -3.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -47.2% | -40.4% | 0.07 | 10.89 | -6.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 3333.1% | -444.8% | -0.14 | 0.81 | -5.3 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -65.8% | -50.4% | 0.22 | 9.12 | -2.6 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -66.5% | -49.3% | 0.26 | 14.39 | -2.4 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -47.5% | -44.0% | 0.03 | 13.23 | -1.5 |
| -1.3 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -34.3% | -25.5% | 0.03 | 4.06 | -1.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -21.8% | -17.5% | 0.04 | 5.46 | -1.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -20.3% | -17.2% | 0.03 | 7.48 | -1.2 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -16.8% | -14.4% | 0.03 | 8.02 | -2.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -7.8% | -7.1% | 0.03 | 13.10 | -6.7 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -10.2% | -9.1% | 0.03 | 10.93 | -6.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -6.3% | -5.9% | 0.02 | 17.99 | -6.8 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -15.9% | -13.5% | 0.07 | 9.49 | -3.8 |